Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
08/15/2012 | CN101850058B Chinese medicament for preventing and treating agrypnia, memory loss and alzheimers disease and method |
08/15/2012 | CN101822697B Preparation method of traditional Chinese medicine ultrafine formula particles |
08/15/2012 | CN101822684B Compound combined preparation for preventing osteoarticular pain and preparation method thereof |
08/15/2012 | CN101780170B Compound capsule containing root of red-rooted salvia and preparation method and quality determination method thereof |
08/15/2012 | CN101766581B Diltiazem hydrochloride timing controlled release tablet in group-hole released way and preparation method thereof |
08/15/2012 | CN101658493B Azithromycin nanostructured lipid carrier and preparation method thereof |
08/15/2012 | CN101637476B Preparation for percutaneous administration and preparation method and application thereof |
08/15/2012 | CN101637444B Anti-cancer drug slow release injection containing gemcitabine |
08/15/2012 | CN101530594B Ultra-fine grain traditional Chinese medicine defibrination paste used for treating liver cirrhosis |
08/15/2012 | CN101524391B Detection method for Xihuang pills |
08/15/2012 | CN101495117B Aqueous liquid preparation containing amide compound |
08/15/2012 | CN101467921B Method for producing bracket for eluting medicament |
08/15/2012 | CN101269158B Medicament combination for treating hypertension, preparation method and quality control method |
08/15/2012 | CN101269116B Detection method of chaihuang soft capsule |
08/15/2012 | CN101172146B Medicament for smoothing lung, relieving cough, eliminating phlegm relieving asthma and preparation method thereof |
08/14/2012 | USRE43582 Semi-moist delivery system |
08/14/2012 | USRE43580 Nasal calcitonin formulations |
08/14/2012 | US8242172 2,2-dimethylbutyric acid oral pharmaceutical compositions |
08/14/2012 | US8242127 Derivatives of pyrimido[6,1-A]isoquinolin-4-one |
08/14/2012 | US8242099 Implants and methods for treating inflammation-mediated conditions of the eye |
08/14/2012 | US8242096 Compositions comprising pectin and ascorbic acid |
08/14/2012 | US8242089 Sphingolipids polyalkylamine conjugates for use in transfection |
08/14/2012 | US8242076 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
08/14/2012 | US8242056 Agriculture actives delivery composition comprising boron and persulfate ion-crosslinked polyvinyl alcohol microcapsules and method of use thereof |
08/14/2012 | US8241765 Fluorescent ink compositions comprising functionalized fluorescent nanocrystals |
08/14/2012 | US8241670 Compositions capable of facilitating penetration across a biological barrier |
08/14/2012 | US8241669 Endoparasiticidal gel composition |
08/14/2012 | US8241668 Polymers contqining ester, thioester or amide groups in backbone which degrade into bioactive material upon hydrolysis |
08/14/2012 | US8241667 Dual controlled release osmotic device |
08/14/2012 | US8241665 Chewable soft capsule |
08/14/2012 | US8241664 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
08/14/2012 | US8241663 Liposome preparation |
08/14/2012 | US8241662 Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy |
08/14/2012 | US8241661 Biocompatible film with variable cross-sectional properties |
08/14/2012 | US8241660 Patch for the expulsion of insect poison from the skin after stings from membranous insects (hymenoptera) |
08/14/2012 | US8241652 Spherical particles; casting three-dimensional structures; mixing emulsifier into aqueous solution containing gelatin; mixing with solvent; solidification; wound healing agents |
08/14/2012 | US8241650 Diabetic neuropathy, antiulcer agents; nitric oxide elution polymer |
08/14/2012 | US8241648 Synthetically modified fullerene molecules; ellipsoid with an equatorial band and two opposing poles; adduct at poles, hydrophobic chemical moiety capable of anchoring the fullerene on or in a lipid membrane; ointment, cream, lotion, moisturized patch or moisture-free patch, shampoo, gel, rinse |
08/14/2012 | US8241647 Amphiphilic molecule, molecular assembly comprising the amphiphilic molecule, and use of the molecular assembly |
08/14/2012 | US8241616 Hair styling composition |
08/14/2012 | US8241610 Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines |
08/14/2012 | US8241609 Method for embolization using liquid embolic materials |
08/14/2012 | US8241270 Drug infusion system and method adapted to start during programming cycle |
08/14/2012 | US8241269 Fluid medication delivery device |
08/14/2012 | US8239978 Vision through photodynamic therapy of the eye |
08/14/2012 | CA2661062C Compositions comprising calcium citrate malate and methods for making the same |
08/14/2012 | CA2632078C Methods of inducing terminal differentiation |
08/14/2012 | CA2553619C Biodegradable multi-block co-polymers |
08/14/2012 | CA2537665C Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
08/14/2012 | CA2530625C Antigen-containing microspheres for allergy therapy |
08/14/2012 | CA2530460C Method of treating acute coronary syndromes |
08/14/2012 | CA2524979C Solid dosage form comprising (s)-pantoprazole magnesium salt |
08/14/2012 | CA2523079C Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts |
08/14/2012 | CA2498233C Clear ophthalmic solution comprising latanoprost as active ingredient |
08/14/2012 | CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
08/14/2012 | CA2494568C Patches containing tulobuterol |
08/14/2012 | CA2469028C Pharmaceutical composition in the form of gel or solution based on dihydrotestosterone, preparation method and uses thereof |
08/14/2012 | CA2452075C Sustained release delivery system |
08/14/2012 | CA2451187C Zero-order prolonged release coaxial implants |
08/14/2012 | CA2332455C Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants |
08/09/2012 | WO2012106714A1 Implantable device for controlled release of low solubility drug |
08/09/2012 | WO2012106713A2 Targeted nanoparticle conjugates |
08/09/2012 | WO2012106669A2 Foxc1 antibodies and methods of their use |
08/09/2012 | WO2012106665A2 Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease |
08/09/2012 | WO2012106662A2 New agents to treat/prevent amoebiasis |
08/09/2012 | WO2012106575A1 Dry powder formulations of particles that contain two or more active ingredients for treating obstructive or inflammatory airways diseases |
08/09/2012 | WO2012106382A1 Aerosol pirfenidone and pyridone analog compounds and uses thereof |
08/09/2012 | WO2012106303A1 Pharmaceutical formulations including an amine compound |
08/09/2012 | WO2012106299A1 Pharmaceutical compositions of cytidine analogs and methods of use thereof |
08/09/2012 | WO2012106281A2 Multimodal trail molecules and uses in cellular therapies |
08/09/2012 | WO2012106118A2 Method of making ophthalmic devices and components thereof from hydrophobic acrylic (ha) polymers with reduced or eliminated glistenings |
08/09/2012 | WO2012105816A2 Composition for preventing and treating diabetes and diabetes complications comprising amphicarpaea edgeworthii var. trisperma powder or an extract thereof |
08/09/2012 | WO2012105815A2 Biodegradable paox microspheres having cationic properties |
08/09/2012 | WO2012105797A2 Structure having nanoantenna and method for manufacturing same |
08/09/2012 | WO2012105794A2 Magnetic nanoparticle, having a curie temperature which is within biocompatible temperature range, and method for preparing same |
08/09/2012 | WO2012105767A2 Antiarrhythmic agent preparations having a ph-independent dissolution profile |
08/09/2012 | WO2012105715A1 Novel external preparation |
08/09/2012 | WO2012105625A1 Transdermal absorption-promoting agent and transdermal patch containing same |
08/09/2012 | WO2012105624A1 Transdermal patch |
08/09/2012 | WO2012105623A1 Production method for adhesive patch |
08/09/2012 | WO2012105622A1 Patch preparation |
08/09/2012 | WO2012105621A1 Production method for adhesive patch |
08/09/2012 | WO2012105620A1 Patch and patch preparation |
08/09/2012 | WO2012105619A1 Patch and patch preparation |
08/09/2012 | WO2012105618A1 Patch preparation |
08/09/2012 | WO2012105551A1 Water-soluble preparation containing physiologically active substance and process for production thereof |
08/09/2012 | WO2012105546A1 Process for producing aqueous solution containing fat-soluble substance |
08/09/2012 | WO2012105542A1 External preparation for skin |
08/09/2012 | WO2012105521A1 Externally-used drug for treating skin disorder and method for producing same |
08/09/2012 | WO2012105485A1 Dermal composition comprising polymeric reversed micelle, and method for producing same |
08/09/2012 | WO2012105467A1 Oligonucleic acid composition and antiallergic agent |
08/09/2012 | WO2012104867A2 Gel film for treating corneal endothelial cell defects |
08/09/2012 | WO2012104818A1 Oral controlled release pharmaceutical compositions of bepotastine |
08/09/2012 | WO2012104752A1 Pharmaceutical composition comprising opioid agonist and sequestered antagonist |
08/09/2012 | WO2012104730A1 Pharmaceutical preparation |
08/09/2012 | WO2012104706A1 New combination for the treatment of pain |
08/09/2012 | WO2012104655A2 Compostions and methods for treating chronic inflammation and inflammatory diseases |
08/09/2012 | WO2012104654A1 Compositions and methods for treating cardiovascular diseases |
08/09/2012 | WO2012104641A2 Pharmaceutical formulation |
08/09/2012 | WO2012104617A1 Improvements in and relating to compositions |